These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8043911)

  • 41. Flow as a regulator of the activation of factor X by tissue factor.
    Gemmell CH; Turitto VT; Nemerson Y
    Blood; 1988 Oct; 72(4):1404-6. PubMed ID: 3262388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor.
    Carson SD
    FEBS Lett; 1981 Sep; 132(1):37-40. PubMed ID: 6795061
    [No Abstract]   [Full Text] [Related]  

  • 43. Tissue factor (coagulation factor III) inhibition by apolipoprotein A-II.
    Carson SD
    J Biol Chem; 1987 Jan; 262(2):718-21. PubMed ID: 3100517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor Xa generation at the surface of cultured rat vascular smooth muscle cells in an in vitro flow system.
    Hall CL; Taubman MB; Nemerson Y; Turitto VT
    J Biomech Eng; 1998 Aug; 120(4):484-90. PubMed ID: 10412419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid and efficient incorporation of tissue factor into liposomes.
    Smith SA; Morrissey JH
    J Thromb Haemost; 2004 Jul; 2(7):1155-62. PubMed ID: 15219199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The activation of factor IX by the tissue factor pathway.
    Rapaport SI
    Prog Clin Biol Res; 1981; 72():57-76. PubMed ID: 7335650
    [No Abstract]   [Full Text] [Related]  

  • 47. The effects of lipoproteins on the tissue factor-dependent activation of factor X.
    Trimarchi A; Minestrini D; Palazzesi G; Cassetti M
    Int J Clin Lab Res; 1992; 22(2):115-8. PubMed ID: 1504304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary procoagulant behaves as tissue factor by promoting factor VIIa-catalyzed activation of factor X.
    Kurosawa S; Matsuda M; Aoki N
    Thromb Res; 1984 Mar; 33(6):595-606. PubMed ID: 6609450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thromboplastin immobilized on polystyrene surface exhibits kinetic characteristics close to those for the native protein and activates in vitro blood coagulation similarly to thromboplastin on fibroblasts.
    Fadeeva OA; Panteleev MA; Karamzin SS; Balandina AN; Smirnov IV; Ataullakhanov FI
    Biochemistry (Mosc); 2010 Jun; 75(6):734-43. PubMed ID: 20636265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the mechanism of inhibition of factor VIIa by synthetic pentasaccharide, low molecular-weight heparins and unfractionated heparin.
    Gerotziafas GT; Samama MM
    Br J Haematol; 2000 Jun; 109(4):903-5. PubMed ID: 10970139
    [No Abstract]   [Full Text] [Related]  

  • 51. [Elimination of autologous factor Xa from the circulation of intact and thymectomized rats].
    Tsybikov NN; Tersenev OI; Byshevskiĭ ASh; Kuznik BI; Shmerkin SG
    Biull Eksp Biol Med; 1982 Sep; 94(9):31-3. PubMed ID: 7171819
    [No Abstract]   [Full Text] [Related]  

  • 52. A continuous flow reactor system for the study of blood coagulation.
    Contino P; Repke D; Nemerson Y
    Thromb Haemost; 1991 Jul; 66(1):138-40. PubMed ID: 1926043
    [No Abstract]   [Full Text] [Related]  

  • 53. [Thromboplastin. A short review of new findings].
    Kase F; Klír P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(5):596-607. PubMed ID: 75126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue factor activity in HeLa cells measured with a continuous chromogenic assay and ELISA reader.
    Carson SD; Archer PG
    Thromb Res; 1986 Jan; 41(2):185-95. PubMed ID: 3515617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of factor X by factor VIIa on monocyte cell surfaces.
    Martin DM; Tuddenham EG
    Blood; 1994 Jun; 83(12):3828-9. PubMed ID: 8204901
    [No Abstract]   [Full Text] [Related]  

  • 56. Different modeling approaches in the simulation of extrinsic coagulation factor X activation: Limitations and areas of applicability.
    Kovalenko TA; Panteleev MA; Sveshnikova AN
    Int J Numer Method Biomed Eng; 2023 Nov; 39(11):e3689. PubMed ID: 36802118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffusion and reaction in the cell glycocalyx and the extracellular matrix.
    Levine HA; McGee MP; Serna S
    J Math Biol; 2010 Jan; 60(1):1-26. PubMed ID: 19274464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coagulation factor X Arg386 specifically affects activation by the intrinsic pathway: a novel patient mutation.
    Vanden Hoek AL; Talbot K; Carter IS; Vickars L; Carter CJ; Jackson SC; MacGillivray RT; Pryzdial EL
    J Thromb Haemost; 2012 Dec; 10(12):2613-5. PubMed ID: 23039000
    [No Abstract]   [Full Text] [Related]  

  • 59. The next best thing in factor VIIa.
    Hoffman M
    J Thromb Haemost; 2018 Oct; 16(10):1911-1913. PubMed ID: 30117258
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of shear rate on activation rate of factor X.
    Katoh S; Matsubara I; Sada E
    Ann Biomed Eng; 1978 Mar; 6(1):60-7. PubMed ID: 717860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.